跳至主要内容
临床试验/NCT00778492
NCT00778492Unknown不适用

Thrombelastogram and Predicting Microvascular Bleeding in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Re-sternotomy d/t Bleeding

研究概览

简要总结

Study Objective is to correlate the results of preoperative platelet mapping derived from modified TEG with clinically significant postoperative bleeding and consumption of blood products.

详细描述

Study Design:

Prospective observational study with blinded assessment of study endpoint variables. Collection of information concerning study endpoints will be performed by the investigator blinded to the results of preoperative testing of platelet function. The information will be collected from 60 patients undergoing cardiac surgery in the Department of Cardiac Surgery of Sheba Medical Center.

Study endpoints

  1. Primary endpoint- resternotomy for bleeding after the surgery.
  2. Secondary endpoints- chest tube output during first 24 hours after the surgery; consumption of blood products during first 3 postoperative days.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing cardiac surgery with the history of aspirin and/or ADP receptor antagonist for at least 7 days prior the surgery

排除标准

  • Emergent surgery
  • Heart transplant surgery
  • Implantation of ventricular assist devices
  • Enrollment into conflicting study

结局指标

主要结局

Re-sternotomy d/t Bleeding

时间窗: Hospitalization Period

次要结局

  • Chest tube output during first 24 hours after the surgery(24 hours)

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验